Agilent Technologies and Accelrys announce software licensing agreement and technology alliance

14-Aug-2002

PALO ALTO, Calif., Aug. 13, 2002 - Agilent Technologies Inc. and Accelrys Inc., a wholly owned subsidiary of Pharmacopeia Inc., today announced a software licensing agreement and technology alliance expected to result in software to assist pharmaceutical and biotech professionals in the development of more effective drugs.

Under the terms of the agreement, Agilent will license the use of Accelrys' Viewer ActiveX Control for 3D visualization of molecular structures. The Viewer ActiveX Control will be integrated into the recently released Agilent Synapsia Informatics Workbench, and will enable scientists and technicians in the pharmaceutical and biotech industry to visualize and share molecular information in a clear and consistent manner across the pharmaceutical value chain. It is expected to further enhance the collaborative knowledge synthesizing capability of Agilent's Informatics software, and therefore help accelerate decision-making in the development of more effective drugs.

Other news from the department research and development

Most read news

More news from our other portals

Discover the latest developments in battery technology!